Literature DB >> 9280037

A truncated poisson regression model with applications to occurrence of adenomatous polyps.

T Xie1, M Aickin.   

Abstract

Adenomatous polyps are considered as the dominant precursor lesion of colorectal cancer. A phase III colorectal cancer prevention trial, conducted by the Arizona Cancer Center, concerns the ability of wheat bran fibre supplement to reduce the recurrence of adenomatous polyps. All participants in the study are to have had colorectal polyps detected and removed during a baseline (qualifying) colonoscopy within three months prior to enrolment. In this paper, our interest focuses on occurrence of adenomatous polyps at the baseline colonoscopy. We use a truncated Poisson model to fit these types of data. We develop a regression model to assess the effects of explanatory factors on the positive counting variable. We fit truncated Poisson parameters by a log-linear regression model and estimate regression parameters by the maximum likelihood procedure. Finally, we apply it to the baseline colonoscopy data from the Wheat Bran Fiber study.

Entities:  

Mesh:

Year:  1997        PMID: 9280037     DOI: 10.1002/(sici)1097-0258(19970830)16:16<1845::aid-sim605>3.0.co;2-g

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  The Zero-truncated Poisson with Right Censoring: an Application to Translational Breast Cancer Research.

Authors:  Hung-Wen Yeh; Byron Gajewski; Purna Mukhopadhyay; Fariba Behbod
Journal:  Stat Biopharm Res       Date:  2012-08-30       Impact factor: 1.452

2.  New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes.

Authors:  Samiran Ghosh; Erina Paul; Shrabanti Chowdhury; Ram C Tiwari
Journal:  Biostatistics       Date:  2022-01-13       Impact factor: 5.899

3.  General practice for the poor and specialist services for the rich: inequality evidence from a cross-sectional survey on Hangzhou residents, China.

Authors:  Tao Zhang; Chaojie Liu; Lingrui Liu; Yong Gan; Wei Lu; Hongbing Tao
Journal:  Int J Equity Health       Date:  2019-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.